Does primary tumor localization has prognostic importance in seminoma patients?: Turkish oncology Group study

Autor: Yildiz, B, Kucukarda, A, Gokyer, A, Demiray, Atike Gökçen, Paydas, S, Aral, IP, Gumusay, O, Bilici, A, Akdeniz, N, Bahceci, A, Demir, H, Esin, E, Uyeturk, U, Okten, IN, Erturk, I, Turk, HM, Topaloglu, US, Basoglu, T, Turhal, NS, Cinkir, HY, Menekse, S, Cakmak, Y, Urun, Y, Acar, R, Kut, E, Dal, P, Sakalar, T, Aktepe, OH, Karadurmus, N

Publikováno v: Scopus-Elsevier

Purpose: The purpose of this study was to determine whether primary tumor localization may be a risk factor for relapse and survival in seminomatous germ cell tumors (GCT) patients. Methods: In our study, 612 seminomatous GCT patients diagnosed in 22

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e405cbfd06e0d54474ffebcd22058f28

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy.

Autor: Güner G; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey.; Department of Medical Oncology, Medical Point Hospital, Izmir Economy University Faculty of Medicine, Izmir 35575, Turkey., Özçakar L; Department of Physical and Rehabilitation Medicine, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey., Baytar Y; Department of Radiology, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey., Onur MR; Department of Radiology, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey., Demir M; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Aktaş BY; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Aktepe OH; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Güven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Taban H; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Yıldırım HÇ; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Akın S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey., Kara M; Department of Physical and Rehabilitation Medicine, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey., Dizdar Ö; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey.

Publikováno v: Cancers [Cancers (Basel)] 2024 Mar 05; Vol. 16 (5). Date of Electronic Publication: 2024 Mar 05.

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards.

Autor: Guven DC; Department of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey., Eroglu I; Department of Internal Medicine, 37515Hacettepe University, Turkey., Ismayilov R; Department of Internal Medicine, 37515Hacettepe University, Turkey., Ulusoydan E; Department of Internal Medicine, 37515Hacettepe University, Turkey., Aktepe OH; Department of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey., Telli Dizman G; Department of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey., Arik Z; Department of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey., Dizdar O; Department of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey., Unal S; Department of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey., Metan G; Department of Clinical Microbiology and Infectious Disease, 37515Hacettepe University, Turkey., Kertmen N; Department of Medical Oncology, 37515Hacettepe University Cancer Institute, Turkey.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2022 Dec; Vol. 28 (8), pp. 1807-1811. Date of Electronic Publication: 2021 Sep 30.

The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study.

Autor: Güven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Yıldırım HÇ; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Erul E; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Şahin TK; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Çakır İY; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Aktepe OH; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Kertmen N; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Dizdar Ö; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Turkish journal of medical sciences [Turk J Med Sci] 2022 Oct; Vol. 52 (5), pp. 1551-1558. Date of Electronic Publication: 2022 Oct 19.

The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy.

Autor: Guven DC; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey., Sahin TK; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey., Erul E; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey., Cakir IY; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey., Ucgul E; Department of Internal Medicine, Faculty of Medicine, Hacettepe University, 06100 Ankara, Turkey., Yildirim HC; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey., Aktepe OH; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey., Erman M; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey., Kilickap S; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey.; Department of Medical Oncology, Faculty of Medicine, Istinye University, 34396 Istanbul, Turkey., Aksoy S; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey., Yalcin S; Department of Medical Oncology, Cancer Institute, Hacettepe University, 06100 Ankara, Turkey.

Publikováno v: Journal of clinical medicine [J Clin Med] 2022 Aug 03; Vol. 11 (15). Date of Electronic Publication: 2022 Aug 03.